These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 23087524

  • 1. Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient.
    Taqi SA, Zaki SA, Nilofer AR, Sami LB.
    Indian J Pharmacol; 2012; 44(4):533-5. PubMed ID: 23087524
    [Abstract] [Full Text] [Related]

  • 2. Trimethoprim/sulfamethoxazole desensitization in an HIV-positive patient with previous Stevens-Johnson syndrome; a failed study.
    Ansari R, Ghaderkhani S, Namazi S.
    Daru; 2023 Jun; 31(1):69-73. PubMed ID: 37002421
    [Abstract] [Full Text] [Related]

  • 3. Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
    Yang JJ, Huang CH, Liu CE, Tang HJ, Yang CJ, Lee YC, Lee KY, Tsai MS, Lin SW, Chen YH, Lu PL, Hung CC.
    PLoS One; 2014 Jun; 9(9):e106141. PubMed ID: 25184238
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-Dose vs Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Not Infected With HIV: A Multicenter, Retrospective Observational Cohort Study.
    Nagai T, Matsui H, Fujioka H, Homma Y, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Tomohisa W, Otsuka Y, Nakashima K.
    Chest; 2024 Jan; 165(1):58-67. PubMed ID: 37574166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG, Nageswaran S, Valentine ME, McKinney RE.
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [Abstract] [Full Text] [Related]

  • 11. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, Ota Y.
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [Abstract] [Full Text] [Related]

  • 12. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
    Langlois MR, Derk F, Belczyk R, Zgonis T.
    J Am Podiatr Med Assoc; 2010 May; 100(4):299-303. PubMed ID: 20660883
    [Abstract] [Full Text] [Related]

  • 13. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R, Spelman D, Czarny D, O'Hehir RE.
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract] [Full Text] [Related]

  • 14. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M, Chau F, Garry L, Farinotti R, Derouin F, Girard PM.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov 01; 13(3):201-7. PubMed ID: 8898664
    [Abstract] [Full Text] [Related]

  • 15. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
    Piketty C, Gilqouin J, Kazatchkine M.
    Ann Med Interne (Paris); 1996 Nov 01; 147(5):327-30. PubMed ID: 9033734
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, Harish A, Poe KL, Park MA.
    J Allergy Clin Immunol Pract; 2014 Nov 01; 2(1):52-8. PubMed ID: 24565769
    [Abstract] [Full Text] [Related]

  • 19. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
    Thomas M, Rupali P, Woodhouse A, Ellis-Pegler R.
    Scand J Infect Dis; 2009 Nov 01; 41(11-12):862-8. PubMed ID: 19922070
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.